Factor IX gene therapy (Valentis)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFactor IX gene therapy (Valentis)

Drug Alias NameN/A

ClassificationBiologics

Mechanisms of ActionCoagulation factor IX stimulants

TargetsCoagulation factor IX

Therapy Area/IndicationsHemophilia B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesValentis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesValentis

Active IndicationsN/A

Inactive IndicationsHemophilia B

ATC CodeN/A